Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Molecular Templates shares are trading higher after the company announced that it will present interim data from its MT-6402 Phase I study in patients with PD-L1+ solid tumors at the 2024 AACR annual meeting.

Author: Benzinga Newsdesk | April 09, 2024 08:29am

Posted In: MTEM